Leadership

Ankit Mitra serves as the Chief Executive Officer and Co-Founder of Ascleon Healthtech Ltd., where he leads the strategic vision for the company's patient-centric platform. With a specialized background blending biotechnology, cell and molecular biology, and computational software engineering, he bridges the gap between complex biological data and intuitive digital solutions. His leadership and scientific pursuits are driven by a core personal ethos to discover, protect, and inspire through scientific innovation.

At Ascleon, Ankit’s work is focused on establishing the foundational digital and corporate architecture of the platform. Leveraging his technical and operational background, he architected the company's initial digital presence, assisted in developing the final Minimum Viable Product (MVP), developing the interactive landing page, securing the domains, and configuring secure enterprise workspaces. Furthermore, his workflows center on structuring the venture for long-term scalability; this includes overseeing Ascleon's Delaware incorporation, legal documentation, and early financial infrastructure. By actively integrating extensive market research and insights from newly onboarded advisors, Ankit continuously refines the company’s pitch materials and strategic roadmap to ensure the platform is optimally positioned for funding success and commercial viability.

Ankit hold's a Master of Science in Biotechnology candidate at Northeastern University, having previously earned a Bachelor of Technology in Biotechnology from Techno India University. Prior to founding Ascleon, he engineered FlowBridge Pro, a standalone macOS application utilizing unsupervised machine learning to autonomously automate high-throughput flow cytometry gating pipelines. His robust experimental and computational background spans diverse disciplines, including executing targeted CRISPR-Cas9 genome editing and identifying novel drug candidates for cancer biology through in silico molecular docking simulations on the USP7 enzyme. Additionally, his clinical and microbiological expertise is highlighted by his research investigating the antimicrobial efficacy of natural lycopene formulations, alongside hands-on training in flow cytometry and separation techniques at the Indian Institute of Chemical Biology.

Varsha Malani is the Chief Technical Officer and Founder of Ascleon Healthtech Ltd., bringing deep expertise in healthcare systems, clinical genetics, and operational leadership to the executive team. In her leadership role, she focuses on bridging the gap between complex genetic data and actionable patient care, ensuring that Ascleon's architecture translates effectively to real-world clinical environments. Her work prioritizes seamless patient experiences, secure infrastructure, and robust scalability for the platform.

At Ascleon, Varsha’s work focuses on architecting and scaling the platform’s core technical and operational ecosystem. She independently designed the initial Minimum Viable Product (MVP) and directly managed its day-to-day functionality, performance, and iterative feature development. She oversees backend development and cloud infrastructure on AWS, ensuring stringent data security, HIPAA alignment, and clinical-grade reliability. Drawing from extensive feedback from advisors and cross-functional team insights, Varsha actively leads the ongoing development, refinement and redesign of the final MVP, continuously optimizing interface intuitiveness and data pipeline workflows to build an agile, scalable product.

Varsha holds a Master's degree in Biotechnology from Northeastern University, where she served as an Academic Senator, and a Bachelor's degree in Biotechnology Engineering from Shivaji University. She is a Board-certified Level 1 Genetic Counselor with a rich clinical history. Notably, she founded and scaled a Human Genetics Department at Bharti Hospital and Medical College, where she established standard operating procedures for Next-Generation Sequencing (NGS) test selection and coordinated over 70 molecular and cytogenetic test partnerships. Her extensive research and clinical background also includes serving as a Research Assistant at Northeastern University's Loring Lab, co-authoring 18 peer-reviewed publications as a Medical Writer for the Dr. Jerath Lab, and managing patient risk assessments and diagnostic reports at Arya Children's Super Specialty Clinic.

Sanjana Nayak serves as the Chief Scientific Officer and Co-Founder of Ascleon Healthtech Ltd., where she leads the scientific vision and biological data integrity for the company's patient-centric platform. With a specialized background blending biotechnology, bioinformatics, and analytical chemistry, she bridges the gap between clinical research and actionable digital health solutions. Her leadership and scientific pursuits are driven by a dual passion for advancing human health and wildlife conservation, anchored by a core personal ethos to discover, protect, and inspire through scientific innovation.

At Ascleon, Sanjana’s work is focused on establishing the foundational scientific validity and clinical architecture of the platform. Leveraging her technical and laboratory background, she ensures the medical data aggregation and AI-driven pedigree parsing remain scientifically rigorous and MDDS-compliant. Furthermore, her workflows center on structuring the venture for long-term clinical integration; this includes overseeing the biomedical parameters required for seamless clinical trial and research study matching. By actively integrating extensive bioinformatics research and insights from the advisory board, Sanjana continuously refines the company’s clinical roadmap to ensure the platform is optimally positioned for healthcare partnerships and commercial viability.

Sanjana is a Master of Science in Biotechnology candidate at Northeastern University, having previously earned a Bachelor of Technology in Biotechnology from Techno India University. Her robust experimental and computational background spans diverse disciplines, including implementing bioinformatics algorithms, designing primers, and conducting advanced separation techniques. Her clinical and microbiological expertise is highlighted by her collaborative research investigating the antibacterial properties of natural lycopene formulations on pathogens like S. aureus and K. pneumoniae, alongside hands-on training in flow cytometry, High-Performance Liquid Chromatography (HPLC), and mammalian cell culture at the Indian Institute of Chemical Biology.